Purchase Order 75D30123P17161

Award Date 8/25/23
Potential Completion Date 9/30/23
Potential Value $127K
Federal Agency
CDC Pittsburgh
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chamblee, GA 30341, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Centers for Disease Control and Prevention (CDC) awarded a Firm Fixed Price Purchase Order to Life Technologies Corporation for the procurement of two QuantStudio 5Dx Real-Time Polymerase Chain Reaction (PCR) Systems and associated accessories. The contract has a ceiling value of $121,206.26 and a completion date of August 20, 2024. This is a commercial item acquisition conducted under Simplified Acquisition Procedures and is not a set-aside. Life Technologies Corporation is a manufacturer...
The Centers for Disease Control and Prevention (CDC) awarded an $81,152.68 firm fixed price purchase order to Life Technologies Corporation for the acquisition of QuantStudio 7 Pro real-time polymerase chain reaction (PCR) systems. As the prime contractor, Life Technologies Corporation will deliver the requested PCR systems to the CDC location in Chamblee, Georgia within the period of performance of September 28, 2023 through November 15, 2023. The funding for this contract was provided by the...
This federal contract award was issued by the Centers for Disease Control and Prevention (CDC) to Life Technologies Corporation, a prime contractor and manufacturer of scientific instruments, reagents, and consumables. The $79,005.12 firm fixed price contract is for the delivery of a QuantStudio DX with 96 Well Fast Block, a desktop genetic analysis system. This award is not associated with a set-aside program. Life Technologies has previously supported the CDC, National Institutes of Health,...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Life Technologies Corporation, a for-profit manufacturer, for the delivery of a QuantStudio 5 DX Thermo instrument. The $111,816.26 contract, which does not have a set-aside designation, is scheduled for completion on December 30, 2022. Life Technologies Corporation is a subsidiary of Thermo Electron Corporation's Financial Services Division, which has previously...
This is a contract award to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc., by the Centers for Disease Control and Prevention (CDC) Pittsburgh for the purchase of a QUANTSTUDIODX system. The $78,925 firm-fixed-price purchase order has a completion date of July 30, 2023. The contract does not have a set-aside designation. Life Technologies Corporation is a leading provider of biomedical research and genetic analysis tools to government agencies. This contract award...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $122,421.28 firm fixed-price purchase order to Life Technologies Corporation, a for-profit manufacturer, to upgrade and deliver a 3730XL (A42442) system. This contract is not associated with any set-aside program. Life Technologies Corporation is a subsidiary of Thermo Electron Corporation, which has previously provided scientific equipment and services to federal agencies such as NIH, USGS, the...
The Centers for Disease Control and Prevention (CDC) awarded a $206,549.95 purchase order to Life Technologies Corporation for the purchase of TaqMan array cards. Life Technologies Corporation, a subsidiary of Thermo Electron Corporation Financial Services Division, will deliver the requested TaqMan array cards to the CDC location in Atlanta, Georgia by September 15, 2023. The firm fixed price contract supports the CDC's disease prevention and health promotion efforts through the acquisition...
The Centers for Disease Control and Prevention, located in Pittsburgh, awarded a $79,600 purchase order to Life Technologies Corporation of Carlsbad, California. Life Technologies, a subsidiary of Thermo Electron Corporation Financial Services Division, will provide THERMO QS7 PRO DX RRT PCR equipment to the CDC under this firm fixed price contract running from September 8th to October 2nd, 2023. No additional details were provided on the original solicitation, but it can be inferred the...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The $70,428.08 contract is for the provision of a QuantStudio QS7ProDx 96 0.2mL block system, a commercial item that will support the CDC's Parasitic Diseases Branch. This requirement was solicited as a combined synopsis/solicitation under Simplified Acquisition Procedures, with no...
This is a $94,249.95 firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The contract is for the delivery of QS5 PCR instrumentation and is not associated with a set-aside program. Life Technologies has previously served as a prime contractor and subcontractor across various federal agencies, including the National Institutes of Health,...

The Centers for Disease Control and Prevention (CDC) awarded a $127,428 purchase order to Life Technologies Corporation to acquire a QUANT STUDIO 5 DX PCR instrument. As a prime contractor, Life Technologies will deliver the requested laboratory equipment to support the CDC's Hepatitis C Laboratory Enhancement Cooperative Agreement (HCVLEC) program. Performance will take place at Life Technologies' facility in Chamblee, Georgia, spanning from August 25 to September 30, 2023. The firm fixed price contract has no set aside designation. This award enables the CDC's hepatitis C prevention and control efforts through expanded diagnostic testing capacity.

Generated 12/15/23, 8:02 PM